Table 1. Baseline characteristics.
| Variables | n = 50 |
|---|---|
| Age (y.o) | 66.5 ± 9.4 |
| Sex (Male, n, %) | 44 (88.0%) |
| Coronary risk factor | |
| Hypertension (n, %) | 45 (90.0%) |
| Dyslipidemia (n, %) | 49 (98.0%) |
| Current smoker (n, %) | 4 (8.0%) |
| Combined drugs | |
| Statins (n, %) | 49 (98.0%) |
| n-3 polyunsaturated fatty acids (n, %) | 16 (32.0%) |
| Calcium channel blocker (n, %) | 20 (40.0%) |
| Angiotensin converting enzyme inhibitors / angiotensin-receptor blocker (n, %) | 36 (72.0%) |
| Dipeptidyl peptidase 4 inhibitors (n, %) | 26 (52.0%) |
| Metformin / thiazolidine (n, %) | 10 (20.0%) |
| Sulfonylurea agent (n, %) | 6 (12.0%) |
| Alpha glucosidase inhibitors (n, %) | 5 (10.0%) |
y.o: years old